持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/11/26 | 3,460 | 3,495 | 3,425 | 3,465 | +40 | +1.2% | 40,900 |
| 2025/11/25 | 3,380 | 3,445 | 3,350 | 3,425 | +65 | +1.9% | 58,400 |
| 2025/11/21 | 3,270 | 3,360 | 3,270 | 3,360 | +60 | +1.8% | 50,100 |
| 2025/11/20 | 3,225 | 3,305 | 3,215 | 3,300 | +90 | +2.8% | 37,000 |
| 2025/11/19 | 3,285 | 3,305 | 3,200 | 3,210 | -105 | -3.2% | 33,400 |
| 2025/11/18 | 3,280 | 3,315 | 3,270 | 3,315 | +5 | +0.2% | 40,800 |
| 2025/11/17 | 3,240 | 3,325 | 3,240 | 3,310 | +55 | +1.7% | 59,200 |
| 2025/11/14 | 3,185 | 3,260 | 3,160 | 3,255 | +75 | +2.4% | 46,100 |
| 2025/11/13 | 3,145 | 3,200 | 3,145 | 3,180 | +35 | +1.1% | 19,900 |
| 2025/11/12 | 3,130 | 3,180 | 3,130 | 3,145 | +35 | +1.1% | 41,300 |
| 2025/11/11 | 3,115 | 3,135 | 3,085 | 3,110 | +10 | +0.3% | 32,100 |
| 2025/11/10 | 3,095 | 3,105 | 3,070 | 3,100 | +10 | +0.3% | 24,600 |
| 2025/11/07 | 3,080 | 3,095 | 3,050 | 3,090 | +10 | +0.3% | 20,700 |
| 2025/11/06 | 3,025 | 3,085 | 3,010 | 3,080 | +45 | +1.5% | 31,400 |
| 2025/11/05 | 3,040 | 3,105 | 2,987 | 3,035 | -10 | -0.3% | 70,900 |
| 2025/11/04 | 2,940 | 3,085 | 2,940 | 3,045 | +97 | +3.3% | 124,500 |
| 2025/10/31 | 2,997 | 2,997 | 2,936 | 2,948 | -4 | -0.1% | 37,900 |
| 2025/10/30 | 2,950 | 2,968 | 2,939 | 2,952 | +2 | +0.1% | 41,000 |
| 2025/10/29 | 3,000 | 3,010 | 2,929 | 2,950 | -60 | -2% | 46,100 |
| 2025/10/28 | 3,095 | 3,095 | 3,010 | 3,010 | -105 | -3.4% | 31,800 |
| 2025/10/27 | 3,110 | 3,125 | 3,080 | 3,115 | +40 | +1.3% | 21,900 |
| 2025/10/24 | 3,080 | 3,095 | 3,060 | 3,075 | -10 | -0.3% | 13,400 |
| 2025/10/23 | 3,075 | 3,120 | 3,075 | 3,085 | +30 | +1% | 22,200 |
| 2025/10/22 | 3,105 | 3,130 | 3,055 | 3,055 | -30 | -1% | 33,600 |
| 2025/10/21 | 3,095 | 3,110 | 3,070 | 3,085 | -5 | -0.2% | 26,200 |
| 2025/10/20 | 3,085 | 3,090 | 3,060 | 3,090 | +40 | +1.3% | 10,700 |
| 2025/10/17 | 3,055 | 3,070 | 3,045 | 3,050 | -30 | -1% | 12,700 |
| 2025/10/16 | 3,055 | 3,085 | 3,050 | 3,080 | +25 | +0.8% | 15,500 |
| 2025/10/15 | 3,065 | 3,090 | 3,030 | 3,055 | +20 | +0.7% | 27,600 |
| 2025/10/14 | 3,050 | 3,060 | 3,005 | 3,035 | -20 | -0.7% | 29,100 |
| 2025/10/10 | 3,080 | 3,095 | 3,055 | 3,055 | -70 | -2.2% | 25,100 |
| 2025/10/09 | 3,100 | 3,135 | 3,100 | 3,125 | +15 | +0.5% | 24,200 |
| 2025/10/08 | 3,130 | 3,175 | 3,110 | 3,110 | -35 | -1.1% | 19,300 |
| 2025/10/07 | 3,130 | 3,165 | 3,130 | 3,145 | -15 | -0.5% | 20,600 |
| 2025/10/06 | 3,200 | 3,200 | 3,135 | 3,160 | +20 | +0.6% | 32,900 |
| 2025/10/03 | 3,090 | 3,160 | 3,090 | 3,140 | +35 | +1.1% | 20,100 |
| 2025/10/02 | 3,080 | 3,130 | 3,060 | 3,105 | +25 | +0.8% | 31,900 |
| 2025/10/01 | 3,130 | 3,175 | 3,080 | 3,080 | -95 | -3% | 41,100 |
| 2025/09/30 | 3,195 | 3,205 | 3,155 | 3,175 | -25 | -0.8% | 33,600 |
| 2025/09/29 | 3,260 | 3,300 | 3,190 | 3,200 | -100 | -3% | 32,300 |
| 2025/09/26 | 3,260 | 3,320 | 3,250 | 3,300 | +45 | +1.4% | 55,500 |
| 2025/09/25 | 3,295 | 3,295 | 3,235 | 3,255 | -45 | -1.4% | 26,600 |
| 2025/09/24 | 3,380 | 3,380 | 3,280 | 3,300 | +60 | +1.9% | 67,300 |
| 2025/09/22 | 3,250 | 3,260 | 3,225 | 3,240 | -15 | -0.5% | 18,200 |
| 2025/09/19 | 3,250 | 3,260 | 3,220 | 3,255 | +40 | +1.2% | 42,400 |
| 2025/09/18 | 3,220 | 3,235 | 3,185 | 3,215 | +10 | +0.3% | 14,100 |
| 2025/09/17 | 3,250 | 3,250 | 3,190 | 3,205 | -45 | -1.4% | 16,900 |
| 2025/09/16 | 3,210 | 3,255 | 3,195 | 3,250 | +40 | +1.2% | 17,600 |
| 2025/09/12 | 3,235 | 3,255 | 3,210 | 3,210 | -15 | -0.5% | 31,700 |
| 2025/09/11 | 3,240 | 3,255 | 3,205 | 3,225 | -15 | -0.5% | 13,800 |
201～
250
件表示中 / 4031件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 328,000円 | +7.7% | +11.7% | 2.59% | 11.54倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 科研薬 | 396,500円 | +17.0% | - | 4.79% | 23.10倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ペプチド | 105,650円 | +72.8% | - | 0.00% | 45.29倍 | 2.80倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ネクセラファーマ | 126,700円 | +39.5% | - | 0.00% | 21.05倍 | 1.79倍 |
|
創薬ベンチャー老舗。買収で成長。低分子で定評の英国創薬事業、日本の製造販売が事業２本柱 |
| ゼリア新薬 | 201,300円 | +6.6% | +17.7% | 2.48% | 8.87倍 | 0.82倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
